Modern patient treatment usually demands the use of non-invasive imaging techniques to evaluate the anatomy, function, or molecular-biological states of patients or research participants. Such imaging techniques can be used alone to provide anatomical or molecular information, or they can be coupled to provide "anato-metabolic" data. In order to enhance diagnostic accuracies, patient comfort, and diagnostic confidence, hybrid imaging refers to image acquisitions on systems that physically integrate complementary imaging modalities. Leading thinkers in clinical research were responsible for the physical fusion of traditionally separate imaging modalities, and it profited from technology advancements that made it possible, for instance, to operate PET and MR next to one another physically. The development of several hybrid imaging systems for use in this evaluation is covered at key points. The development of several hybrid imaging technologies for use in small-animal research and clinical practise is covered in this review's milestones. The introduction of methodological concepts that profit from the availability of complementary anatomical and biological information, such as new types of image reconstruction and data correction schemes, as well as technological advancements that aided in the adoption of hybrid imaging are both given special attention. Hybrid imaging's ultimate objective is to offer helpful, complementary, and quantitative data during patient evaluation. Hybrid imaging also makes it possible to examine illnesses on a multi-parametric level, which will enable us to learn more about the underlying causes of the many conditions that now account for a significant portion of healthcare spending.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia